The expression of several specific biological markers have been used to provide additional prognostic information for NPC patients, including epidermal growth factor receptor [5], serum lactate dehydrogenase (LDH) [6], C-reactive protein (CRP) [7], and plasma Epstein-Barr virus DNA (EBV DNA) [8]. This evidence concerns the gene CRP and nasopharyngeal carcinoma.